Home › Funds › Defilade Capital Management, L.P. › RVMD

Defilade Capital Management, L.P. position in RVMD

REVOLUTION MEDICINES INC · Health Care

Defilade Capital Management, L.P. reported holding 82,827 shares of RVMD (REVOLUTION MEDICINES INC) in its Q2 2026 13F filing — a position valued at US$15.5M, representing 2.08% of its reported portfolio and ranking #18 among its reported holdings. Defilade Capital Management, L.P. has disclosed RVMD holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)82.83K sh
Reported value held$15.51M
Portfolio Weight2.08%
First reportedQ4 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Defilade Capital Management, L.P.'s RVMD position evolved

Defilade Capital Management, L.P. first disclosed a stake in RVMD in Q4 2025 at 363,454 shares (US$28.9M). The position peaked in Q1 2026 at 315,972 shares, worth US$30.7M. Across 3 filings, Defilade Capital Management, L.P. increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 82,827 shares valued at US$15.5M — a reduction of -233,145 shares quarter over quarter.. Notable position changes include a 74% trim in Q2 2026 (shares rose 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 363.45K $28.95M New
Q1 2026 315.97K $30.73M Reduce
Q2 2026 82.83K $15.51M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RVMD and 13F data

RVMD (REVOLUTION MEDICINES INC) is a Health Care company. 61 other funds we track also report a position in RVMD — the largest reported positions include Farallon Capital Management (US$2.54B), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$2.54B), BAKER BROS. ADVISORS LP (US$2.14B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RVMD

All RVMD fund holders →

FAQ

How long has Defilade Capital Management, L.P. held RVMD?

Defilade Capital Management, L.P. has disclosed RVMD holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is Defilade Capital Management, L.P.'s current position in RVMD?

As of Q2 2026, Defilade Capital Management, L.P. holds 82.83K shares of RVMD (REVOLUTION MEDICINES INC), valued at $15.51M, representing 2.08% of its reported portfolio and ranking #18.

Has Defilade Capital Management, L.P. been buying or selling RVMD?

In the latest 13F filing (Q2 2026), Defilade Capital Management, L.P. reduced its position in RVMD. The position peaked in Q1 2026 at 315.97K shares.

Which other funds hold RVMD?

Other major institutional holders of RVMD include Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., BAKER BROS. ADVISORS LP, among 61 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.